Pharmaceutical formulation -514

PK200900905A0Active Publication Date: 2009-11-18KUDOS PHARM LIMETED
0 Cites 0 Cited by

Patent Information

Application Number
PK200900905
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2009-10-05
Publication Date
2009-11-18
Patent Text Reader

Abstract

The present invention relates to a pharmaceutical formulation comprising the drug 4-[3-(4cyclopropanecarbonyl-piperazine-1-carbonyl)-4fluoro-benzyl]-2H-phthalazin-1-one in a solid dispersion with a matrix polymer that exhibits low hygroscopicity and high softening temperature, such as copovidone. The invention also relates to a daily pharmaceutical dose of the drug provided by such a formulation. In addition, the invention relates to the use of a matrix polymer that exhibits low hygroscopicity and high softening temperature in solid dispersion with 4-[3-(4cyclopropanecarbonyl-piperazine- 1-carbonyl)-4fluoro-benzyl]-2H-phthalazin-1-one for increasing the bioavailability of the drug
Need to check novelty before this filing date? Find Prior Art